… Parkinson's disease (PD) diagnosis relies primarily on clinical evaluation due to … patients. PD-BL samples were collected within 2 years from diagnosis and presented abnormal DaTscans, while SWEDD …

… these will reveal whether the markers can be applied for early detection of Parkinson’s disease. Relevance to Diagnosis/Treatment of Parkinson’s Disease: Typically, … need exists for new, robust biomarkers that can detect the early PD stages. These biomarkers will be indispensable in …

… Yet when it comes to the vast enterprise of biomedical research, there's room to question how well the system we've … illness or injury? Over $100 billion is spent on biomedical research each year. Roughly a third of that money goes … are strategically allocated to converting basic discoveries into truly new therapies. This is a higher-risk and …

… Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical … trials and clinical practice. A particularly active area of research is the development of novel molecular imaging … in our audience. These episodes offer a deeper dive into exciting new scientific research on Parkinson’s …

… that currently has no cure and is difficult to diagnose early. A key feature of PD is the abnormal buildup of a protein called alpha-synuclein in brain cells. Recent research shows that small particles released from nerve … in the blood that could help detect PD early. Impact on Diagnosis/Treatment of Parkinson’s disease:  If successful, …

… in 2000, he had a vision to bring people living with PD and researchers together into a two-way dialogue.  Today, nearly 50,000 people — with and without Parkinson’s disease — …